FAT1 and cancer: In another ICI cohort, we could not fully validate the prognostic value of the signature because of insufficient coverage of the Memorial Sloan Kettering Cancer Center panel, but we observed a significant correlation of FAT1 mutation with longer OS (Supplemental Figure 11G).